| Title: | The LARS: A Proposed Approach for FDA Evaluation of Home Testing Products |
| Author: | Zablow, Sheila |
| Citation: | The LARS: A Proposed Approach for FDA Evaluation of Home Testing Products (1996 Third Year Paper) |
| Full Text & Related Files: |
szablow3.pdf (321.1Kb; PDF)
szablow3.rtf (175.9Kb; RTF file)
szablow3.html (134.9Kb; HTML)
|
| Abstract: | This paper critiques the manner in which the Food and Drug Administration uses its discretionary authority to regulate the sale of home testing products. Part I provides the legal framework for FDA approval of home testing products and emphasizes the discretionary authority enjoyed by the agency. In particular, Part I details the responsibility of the FDA to ensure that marketed devices are both safe and effective. Part II details the manner in which the FDA has used its discretionary authority to prevent the sale of HIV blood collection kits. It supports the argument that the current system of regulation is marked by the FDA's excessive use of its statutory discretion. |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:10015316 |
Contact administrator regarding this item (to report mistakes or request changes)